Optometry News

CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Shivani Kamat, MD, of UT Southwestern Medical Center in Texas, shares her experiences with in vitro fertilization as a woman in medicine.

CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Cari Stone of Elios Vision previews the company’s excimer laser for the treatment of glaucoma.

People in underserved areas who took part in a free eye disease screening program were found to be underusing eye care services despite being at high risk, according to a study published in JAMA Ophthalmology.

While most optometry students demonstrate high technology self-efficacy, they may require training to boost telehealth acceptance, according to research published in Clinical and Experimental Optometry.

Clinicians will gather for AIMed24 to meet with industry leaders and innovators and attend keynotes and workshops to discuss the future of AI implementation in medicine, according to information from the meeting organizers.

Less than 25% of patients with thyroid eye disease who underwent a full course of treatment with Tepezza required re-treatment, according to a study published in Ophthalmology.

CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Carey Powers of Powers & Company highlights volunteer efforts across ophthalmology that are changing patients’ lives for the better.

Attempts to curtail prior authorizations for patients insured by Medicare Advantage plans have failed in back-to-back legislative sessions in 2019 and 2021, but a new bill has some experts hopeful that the third time is a charm.

CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Yuna Rapoport, MD, MPH, of Manhattan Eye, discusses light heat therapy for dry eye disease and lotilaner for Demodex blepharitis.

Retinal ganglion cell layer thickness was significantly reduced in patients with severe COVID-19, which indicates an affinity for nerve cells, according to research published in the Open Journal of Ophthalmology.